Skip to main content

View full-text article in PMC

. 2013 Jan 26;21(5):1453–1460. doi: 10.1007/s00520-012-1691-5

Table 2.

Complete response rates in patients with or without concomitant dexamethasone (FAS)

			Oral palonosetron			IV palonosetron
			0.25 mg (N = 155)	0.50 mg (N = 160)	0.75 mg (N = 158)	0.25 mg (N = 162)
			% [95 % CI]	% [95 % CI]	% [95 % CI]	% [95 % CI]
0–24 h	Total		73.5 [65.8, 80.2]	76.3 [68.8, 82.5]	74.1 [66.4, 80.5]	70.4 [62.7, 77.1]
	DEX	Yes^a	76.9 [65.8, 85.4]	86.1 [76.0, 92.5]	85.0 [74.9, 91.7]	82.9 [72.7, 90.0]
	DEX	No^b	70.1 [58.5, 79.8]	66.7 [55.2, 76.5]	62.8 [51.1, 73.3]	57.5 [46.0, 68.3]
24–120 h	Total		59.4 [46.7, 62.8]	62.5 [50.7, 66.4]	60.1 [46.3, 62.3]	65.4 [52.5, 68.0]
	DEX	Yes^a	57.7 [46.0, 68.6]	63.3 [51.6, 73.6]	63.8 [52.2, 74.0]	68.3 [57.0, 77.9]
	DEX	No^b	61.0 [49.2, 71.7]	61.7 [50.2, 72.1]	56.4 [44.7, 67.4]	62.5 [50.9, 72.9]
0–120 h	Total		53.5 [45.4, 61.5]	58.8 [50.7, 66.4]	53.2 [45.1, 61.1]	59.3 [51.3, 66.8]
	DEX	Yes^a	52.6 [41.0, 63.9]	63.3 [51.6, 73.6]	58.8 [47.2, 69.5]	65.9 [54.5, 75.7]
	DEX	No^b	54.5 [42.8, 65.8]	54.3 [42.9, 65.3]	47.4 [36.1, 59.0]	52.5 [41.1, 63.7]

^a N = 319 with dexamethasone

^b N = 316 without dexamethasone